This Association is hosting their 57th ERA- EDTA Congress from June 6th to 9th in Milan: Werfen will be there with a booth to welcome attendees from all over Europe, ready to explore new paths and to be fascinated by innovations and developments in the world of nephrology.
This is the place you want to be to meet and network with ERA-EDTA leaders. It is a wonderful opportunity to get in contact with key opinion leaders and key trends in nephrology!
As the President of ERA-EDTA, Carmine Zoccali, said: “The ERA-EDTA has gradually and successfully grown to respond to the challenges posed by scientific research on renal diseases, to the need to provide high-quality education on these diseases, and the importance of effective relationships with the institutions that fund scientific research in Europe”.
It will be a unique opportunity to introduce your partners to very fascinating and exciting news and make them appreciate the added value that Werfen is delivering to their daily activities, thus greatly improving patient care and outcomes.
At our booth, they will appreciate how issues like thrombotic microangiopathies (TMA) diagnosis are now easier with HemosIL ADAMTS-13 activity assay, a “30-minutes ease-to-use” tool helpful in differentiating thrombotic thrombocytopenic purpura diagnosis from other TMAs, like atypical haemolytic uremic syndrome (aHUS).
They will also have the chance to learn more about the new diagnostic approach that Werfen is implementing on autoimmune disease diagnosis, by shortening diagnosis time.
During this event, Werfen will host an industry symposium on June 8th, aimed at discussing the clinical value that Glycated Albumin offers to manage patients suffering from diabetes or diabetic nephropathy.
Glycated Albumin is a mid-term glycaemic marker that reflects the average life of albumin. It is a unique marker capable to address and evaluate glycaemic status in DKD patients, highlighting therapy adherence and success or changes in glycaemic profiles and to reduce the risk of micro and macro vascular complications of diabetes mellitus.
Spread the news and meet with us at ERA-EDTA Annual Congress: Werfen will be happy to welcome you in this innovative journey in nephrology!
Visit our WebApp on Glycated Albumin for more information: GA.werfen.com
Clinical Chemistry Strategic Business Unit
ERA-EDTA, European Renal Association – European Dialysis and Transplant Association, is a major association of physicians having the goal of promoting the advancement of medical science fundamental and clinical advances in the field of nephrology, dialysis, renal transplantation, hypertension, and related subjects.